ST绿康12月19日公告，公司拟与浦城县土地储备中心签署《收购合同》，收储总价款为人民币18,682万 元，其中：绿康生化股份有限公司17,392万元、福建绿安生物农药有限公司1,290万元。将绿康生化南浦 生态园区及福建绿安生物农药有限公司厂区搬迁至浦潭生物产业园区，浦城县土地储备中心对公司进行 货币补偿。 ...

每经头条（nbdtoutiao）——"一针两千，童颜针年销3亿元"背后：多家关联方注册地"查无此人"，股民 追问"钱呢"！钱氏姐弟几乎"掏空"江苏吴中，公司即将退市 （记者 王晓波） 截至发稿，*ST绿康市值为54亿元。 每经AI快讯，*ST绿康（SZ 002868，收盘价：34.7元）12月15日晚间发布公告称，公司第五届第二十九 次董事会临时会议于2025年12月15日在公司综合办公楼二楼第一会议室以现场结合通讯会议方式召开。 会议审议了《关于2023年员工持股计划预留第二部分受让股份第二个锁定期届满的议案》等文件。 2025年1至6月份，*ST绿康的营业收入构成为：兽药占比61.79%，光伏胶膜占比26.1%，生物农药占比 5.99%，其他占比2.83%，食品添加剂占比2.19%。 ...

Group 1 - The core point of the article is the announcement by *ST Lvkang regarding its board meeting and the composition of its revenue for the first half of 2025 [1] - The board meeting was held on December 8, 2025, to discuss the proposal for the temporary shareholders' meeting [1] - The revenue composition for *ST Lvkang in the first half of 2025 is as follows: veterinary medicine 61.79%, photovoltaic film 26.1%, biopesticides 5.99%, others 2.83%, and food additives 2.19% [1] Group 2 - As of the report, *ST Lvkang has a market capitalization of 5.7 billion yuan [1]

11月25日，钱江生化涨5.08%，截至发稿，报6.41元/股，成交5530.66万元，换手率2.84%，总市值55.55 亿元。 从基金十大重仓股角度 责任编辑：小浪快报 民生加银国证2000指数增强A（019814）基金经理为何江。 截至发稿，何江累计任职时间14年189天，现任基金资产总规模8.64亿元，任职期间最佳基金回报 57.31%， 任职期间最差基金回报-49.3%。 资料显示，浙江钱江生物化学股份有限公司位于浙江省海宁市海洲街道钱江西路178号钱江大厦，成立 日期1993年10月28日，上市日期1997年4月8日，公司主营业务涉及环保综合治理、生物制造及热电业 务。从事的主要业务包括环保工程业务、固废医废危废处置业务、污水处理业务及自来水制水业务。从 事植物生长调节剂、杀虫剂、杀菌剂为主的生物农药产品的研发、生产和销售。从事发电供热业务。主 营业务收入构成为：污水处理29.75%，工程施工21.08%，废弃物清运及处置19.04%，生物制品 18.06%，自来水供应6.70%，热电供应4.51%，其他(补充)0.49%，其他0.38%。 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发 ...

Core Viewpoint - *ST Lvkang has completed a share transfer to Zongteng Network, changing its controlling shareholder and actual controller, which may impact its future strategic direction and operations [1] Group 1: Share Transfer Details - On November 24, 2025, *ST Lvkang announced that it received notification from Kangyi Investment regarding the completion of share transfer procedures related to Zongteng Network [1] - Following the share transfer, Zongteng Network holds approximately 46.61 million shares of *ST Lvkang, accounting for 29.99% of the total share capital [1] - The controlling shareholder has changed from Kangyi Investment to Zongteng Network, with the actual controller shifting from Lai Tanping to Wang Zuan [1] Group 2: Financial Performance - For the first half of 2025, *ST Lvkang's revenue composition was as follows: veterinary medicine 61.79%, photovoltaic film 26.1%, biopesticides 5.99%, others 2.83%, and food additives 2.19% [1] - As of the report date, *ST Lvkang's market capitalization is 6.2 billion yuan [1]

Core Viewpoint - Recently, Qujing Xingzhiyuan Biotechnology Co., Ltd. was established with a registered capital of 1 million RMB, focusing on the production of fertilizers and retail of pesticides [1] Company Overview - The legal representative of the company is Lai Li [1] - The registered capital is 1 million RMB [1] Business Scope - The company is involved in various licensed projects including fertilizer production and pesticide retail, which require approval from relevant authorities before operation [1] - General projects include: - Research and development of bio-organic fertilizers [1] - Research and development of biochemical products [1] - Research and development of biopesticide technology [1] - Research and development of bio-based materials technology [1] - Technical services, development, consulting, exchange, transfer, and promotion [1] - Research and development of biological feed [1] - Sales of fertilizers [1] - Environmental sanitation management (excluding certain monitoring and disposal services) [1] - Water pollution control and prevention services [1] - Soil pollution control and remediation services [1] - Sales of ecological environmental materials [1] - Environmental consulting services [1] - Seed business (limited to un-repackaged seeds) [1] - Sales of new membrane materials [1] - Sales of food additives [1] - Sales of chemical products (excluding licensed chemical products) [1]

Core Insights - A new company, Shijiazhuang Nongyi Biotechnology Co., Ltd., has been established with a registered capital of 500,000 RMB [1] Company Overview - The legal representative of the company is Deng Ting [1] - The company’s business scope includes general projects such as research and development of biopesticide technology, technical services, and sales of various products including chemical products, pesticides, fertilizers, daily necessities, cosmetics, and plastic products [1] - The company is also involved in import and export activities, including technology import and export, and has specific licensed projects for pesticide wholesale and retail, which require approval from relevant authorities [1]

Core Viewpoint - The company is undergoing a strategic transformation from a trading firm to an integrated high-tech enterprise, focusing on agricultural science and specialty oils, while navigating a complex external environment characterized by economic slowdowns and geopolitical tensions [7][10]. Financial Performance - For the first three quarters of 2025, the company achieved a revenue of 63.484 billion yuan, a decrease of 4.68% year-on-year, but turned a profit with a net profit of 32 million yuan compared to a loss in the previous year [7]. - As of September 30, 2025, total assets reached 8.425 billion yuan, up 8.05% from the end of the previous year, while equity attributable to shareholders increased by 1.12% to 2.376 billion yuan [7]. Business Segments Crop Science - The company has been in the agricultural sector for over four years, focusing on biological pesticides and microbial agents, and is extending its agricultural value chain from seed quality to integrated order services for agricultural products [8][10]. - The crop science segment has strengthened its industrial foundation and increased its product pipeline, holding 75 invention patents and 39 utility model patents, with a focus on high-value products [9][10]. Trading Sector - The trading sector remains a core business, maintaining market leadership and strategic partnerships with global firms, while emphasizing risk management and stable operations amid external uncertainties [11][12]. - The company has enhanced its risk warning system and optimized its organizational structure to adapt to market changes, focusing on core business strengths [12][13]. Specialty Oils - The specialty oils segment is driven by a dual strategy of technology leadership and service empowerment, focusing on high-value, high-margin products [14][15]. - The company has invested in R&D to enhance product quality and market competitiveness, successfully launching new high-end products that meet industry standards [15][16]. Corporate Governance - The company has approved several resolutions to streamline management and improve operational efficiency, including the absorption of subsidiaries to reduce management costs [25][41]. - Recent board meetings have focused on enhancing governance structures and ensuring compliance with regulatory requirements [29][30].

Core Insights - Hefei Muyin Biotechnology Co., Ltd. has been established with a registered capital of 2 million RMB [1] - The company is involved in various business activities including research and development of biopesticides and new materials, as well as sales of chemical products and fertilizers [1] Company Overview - The legal representative of the company is Xu Chunsheng [1] - The company’s business scope includes general projects such as technology services, technical development, and consulting [1] - The company is also engaged in the sale of specialized chemical products, agricultural chemicals, and machinery [1] Regulatory Compliance - The company is required to obtain approval for certain activities, such as pesticide wholesale, which must be conducted in accordance with relevant regulations [1] - The operational activities are subject to legal and regulatory compliance, ensuring that the company adheres to laws governing its business operations [1]

Group 1 - The company Zhejiang Qianjiang Biochemical Co., Ltd. announced the listing of 2,000,000 restricted shares on September 5, 2025, which were acquired through a private placement approved by the China Securities Regulatory Commission on December 6, 2021 [2] - The shares were obtained by Mr. Chen Mian through judicial auction, and the lock-up period of 36 months has ended, during which he complied with all relevant commitments [2] - The company has a registered capital of 8,665.85766 million RMB and is primarily engaged in ecological environmental protection, biopesticides, and water operations [2] Group 2 - The company has 26 affiliated companies, including Zhejiang Haiyun Environmental Protection Co., Ltd. and Haining Haiyun Changxin Environmental Engineering Co., Ltd. [3] - The company's revenue for 2022 to 2024 is projected to be 2.009 billion, 2.034 billion, and 1.768 billion RMB, with year-on-year growth rates of -1.09%, 1.27%, and -13.08% respectively [3] - The net profit attributable to the parent company for the same period is expected to be 206 million, 211 million, and 160 million RMB, with year-on-year growth rates of 39.28%, 2.25%, and -24.06% respectively [3]